GAITHERSBURG, Md.--(BUSINESS WIRE)--GenVec, Inc. (Nasdaq:GNVC) will hold a conference call on Wednesday, June 6, 2007 at 8:30 a.m. ET (5:30 a.m. PT) to discuss data from its ongoing pivotal clinical trial of TNFerade™, for locally advanced pancreatic cancer, which was presented on June 2 at the annual meeting of the American Society of Clinical Oncology in Chicago, IL.
